2022 Speaker Line-Up

Shree Patel

SVP Global Clinical Operations & Supply Chain

Achilles Therapeutics

Marco Alessandrini

CTO

Antion Biosciences

Sven Kili

CEO

Antion Biosciences

Miguel Forte

CEO

Bone Therapeutics

Stefanos Theoharis

CBO

Bone Therapeutics

André Choulika

CEO

Cellectis

David Sourdive

Co-Founder, EVP CMC & Manufacturing

Cellectis

Philippe Duchateau

CSO

Cellectis

Robert Igarashi

Head of Kiadis Research

Kiadis Pharma - A Sanofi Company

Goncalo Regalo

Application Scientist

FUJIFILM Irvine Scientific

Dimitrios Wagner

Head of R&D

Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin

Mark Lowdell

Professor of Cell & Tissue Therapy

University College London

Lior Raviv

CTO

Pluristem Therapeutics

Matthias von Herrath

VP & Senior Medical Officer

Novo Nordisk

John Johnston

Clinical Assessor

MHRA

Kimberly Schluns

Senior Director, Research

Kite Pharma

Roland Fleck

Professor of Ultrastructural Imaging

King’s College London

Laurens Sand

Sr. Scientist

Gadeta

Evren Alici

Head of Cell & Gene Therapy

Karolinska Institutet

Arik Hasson

Executive VP for Research & Development

Kadimastem Ltd.

Satwinder Kaur Singh

Director Research

Immunicum

Troels Jordansen

CEO

Glycostem Therapeutics

Kai Pinkernell

CMO

Glycostem Therapeutics

Vicki Coutinho

VP of Regulatory Affairs & Quality

GammaDelta Therapeutics

Sharon Longhurst

VP Development

Gadeta